Anti-tumor drug with lidocaine

An anti-tumor drug, lidocaine technology, applied in the field of anti-tumor drugs containing lidocaine, can solve problems such as difficulty in treatment work

Active Publication Date: 2016-01-20
SHANXI TUMOUR INST
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, there will be cases that are not sensitive to a variety of antitu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Effect of lidocaine alone or in combination with mitomycin on inhibition of human bladder cancer cell line BIU-87.

[0015] Taking human bladder cancer cell line BIU-87 as the target cells, the inhibitory effects of lidocaine and mitomycin alone and in combination on the target cells were detected by MTT colorimetry.

[0016] 1 material

[0017] 1.1 Cell line Human bladder cancer cell line BIU-87 was donated by Yang Xiaofeng, director of the Urology Department of the First Affiliated Hospital of Shanxi Medical University.

[0018] 1.2 Lidocaine hydrochloride injection, specification: 10ml:0.2g, batch number: 20141118, valid until October 2017; mitomycin for injection, specification: 2mg, batch number: 130803, valid until July 2016, Zhejiang Hisun Pharmaceutical Co., Ltd. company.

[0019] 1.3 Reagents and consumables RPMI 1640 medium was purchased from Gibco in the United States, fetal bovine serum was purchased from Hangzhou Sijiqing Bioengineering Materials Co.,...

Embodiment 2

[0035] Effects of lidocaine alone or in combination with pirarubicin on killing BIU-87 cells.

[0036]The human bladder cancer cell line BIU-87 was used as the target cell, and the inhibitory effect of pirarubicin alone and in combination with lidocaine on the target cell was detected by MTT colorimetry.

[0037] 1 material

[0038] 1.1 Cell line Human bladder cancer cell line BIU-87 was donated by Yang Xiaofeng, director of the Urology Department of the First Affiliated Hospital of Shanxi Medical University.

[0039] 1.2 Lidocaine hydrochloride injection, specification: 10ml:0.2g, batch number: 20141118, valid until October 2017; pirarubicin hydrochloride for injection, specification: 10mg, batch number: 1410C15, valid until September 2016, Shenzhen Wanle Pharmaceutical Co., Ltd. company.

[0040] 1.3 Reagents and consumables RPMI 1640 medium was purchased from Gibco in the United States, fetal bovine serum was purchased from Hangzhou Sijiqing Bioengineering Materials C...

Embodiment 3

[0056] Effects of lidocaine alone or combined with Sufuning lotion on killing BIU-87 cells.

[0057] Taking the human bladder cancer cell line BIU-87 as the target cells, the inhibitory effect of Sufuning lotion alone and combined with lidocaine on the target cells was detected by MTT colorimetry.

[0058] 1 material

[0059] 1.1 Cell line Human bladder cancer cell line BIU-87 was donated by Yang Xiaofeng, director of the Urology Department of the First Affiliated Hospital of Shanxi Medical University.

[0060] 1.2 Drug lidocaine hydrochloride injection, specification: 10ml:0.2g, batch number: 20141118, valid until 2017.10; Sufuning Lotion (lyophilized) (SFN), specification: 125mg, batch number: 20140218, valid until 2016.02.17, issued by Provided by the Animal Laboratory of Shanxi Cancer Hospital.

[0061] 1.3 Reagents and consumables RPMI 1640 medium was purchased from Gibco in the United States, fetal bovine serum was purchased from Hangzhou Sijiqing Bioengineering Ma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Login to view more

Abstract

The invention relates to an anti-tumor drug with lidocaine. The lidocaine with the concentration being 1.25-5 mg/ml is dissolved in a solvent acceptable in medicine to form a solution, or the lidocaine is combined with a common bladder cancer resisting infusion drug to form perfusate. The prepared drug liquid is immediately taken according to a using method, the drug liquid is injected into a bladder cavity through a catheter, kept in the bladder cavity for 60-90 min and automatically drained out. The lidocaine can directly inhibit tumor cells under a certain concentration, and the inhibiting effect is enhanced along with increasing of the drug concentration. When the lidocaine is combined with an anti-tumor drug for application, the tumor inhibiting effect of the anti-tumor drug can be enhanced through the lidocaine, the anti-tumor effect of the chemotherapy drug is improved, particularly, the irritation and toxic effect of the chemotherapy drug on a human body is lowered during local application treatment of tumors, the local pain is relieved, and the tumor treatment effect is improved.

Description

technical field [0001] The invention relates to an antitumor drug, in particular to an antitumor drug containing lidocaine for treating bladder cancer. Background technique [0002] Bladder cancer is one of the most common malignant tumors of the urinary system, ranking fourth in the United States and eighth in my country. Ninety percent of bladder cancers are transitional cell carcinomas, of which 70% are superficial bladder cancers, that is, tumors confined to the lamina propria of the bladder mucosa. Bladder cancer has a high recurrence rate. About 40%-70% of patients treated with surgery alone will relapse within two years, and the five-year recurrence rate of superficial bladder cancer can reach 90%, and about 10% can progress to invasive bladder cancer. According to the characteristics of easy recurrence of bladder cancer, postoperative intravesical infusion of drugs can achieve the purpose of removing residual tumor, preventing recurrence and delaying progression. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/167A61K45/00A61P35/00
Inventor 杨喜花任连生张蘋
Owner SHANXI TUMOUR INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap